Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Neuroncell-EX by Cytopeutics for Acute Ischemic Stroke: Likelihood of Approval
Neuroncell-EX is under clinical development by Cytopeutics and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase...